ADMP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 Sep 2023 @ 15:59):

Stats
Today's Volume	119 482
Average Volume	3.11M
Market Cap	7.25M
EPS	$0.0493 ( Q3 \| 2023-11-14 )
Next earnings date	( $0 ) 2024-08-19
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0764 (Sector) 42.63 (Industry) 0
ATR14	$0.190 (30.44%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX 0.71%

AKAN -2.16%

ALIM -0.72%

AMPH -3.73%

AMYT 0.00%

ANIP -0.38%

AQST -5.77%

ASRT -4.03%

ATNX 0.00%

AVDL 0.43%

AYTU -2.06%

BFRI -0.67%

BGXX 8.76%

CLVR -1.52%

COLL 1.30%

CPIX -3.27%

CRDL -0.99%

CRON -1.29%

CYTH -5.51%

DCPH 0.00%

DERM -4.79%

DRRX 1.55%

DVAX -0.62%

EGRX -1.25%

EMBC -2.80%

EMBCV -9.33%

EOLS 2.12%

ESPR 5.41%

EVOK -10.81%

FLGC -2.94%

FLXN 0.00%

GHSI -2.08%

HCM 2.57%

HROW 0.77%

HUGE -14.49%

IMCC -3.43%

INCR 1.00%

IRWD 0.00%

ITCI -0.73%

IXHL 0.34%

JUPW 11.76%

KALA -2.82%

KIN 0.11%

KMDA -3.40%

LNTH -0.36%

NBIX 1.77%

NEPT 0.00%

NLTX 1.45%

OGI 0.00%

OPTN 0.96%

ORGO -3.57%

PAHC 1.61%

PCRX -0.52%

PETQ 3.67%

PLXP 0.00%

PPD 0.00%

PROC 3.16%

PRPH -2.87%

PTPI -5.66%

RDHL -2.00%

RDUS 0.13%

REPH -0.48%

RGC -5.03%

RMTI -5.11%

SCTL 0.92%

SCYX -2.50%

SIGA -0.53%

SISI -14.23%

SNDL 1.05%

SNOA 8.44%

SSIC -2.37%

SUPN -0.75%

SXTC -2.79%

THTX -1.41%

TKNO -11.68%

TLGT -13.85%

TLRY 1.20%

TXMD 6.21%

TYHT -3.90%

UPC 2.08%

VTRS -0.38%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2023-10-23	Dorbin John W. Jr.	Buy	70 000	Employee Stock Option (right to buy)
2023-10-23	Dorbin John W. Jr.	Buy	0
2023-10-16	Cohen Seth	Buy	151 416	Employee Stock Option (right to buy)
2023-10-16	Cohen Seth	Buy	0
2023-09-15	Versi Ebrahim	Buy	729 200	Common Stock

INSIDER POWER
96.85
Last 88 transactions
Buy: 1 947 813 \| Sell: 1 308 563

Volume Correlation

Long: -0.04 (neutral)

Short: -0.22 (neutral)

Signal:(43.501) Neutral

Adamis Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Adamis Pharmaceuticals Correlation - Currency/Commodity

0.60
( weak )

0.49
( neutral )

0.89
( strong )

0.17
( neutral )

-0.77
( moderate negative )

-0.33
( neutral )

Adamis Pharmaceuticals Financials

Annual	2022
Revenue:	$4.76M
Gross Profit:	$-1.43M (-30.10 %)
EPS:	$-12.24

FY	2022
Revenue:	$4.76M
Gross Profit:	$-1.43M (-30.10 %)
EPS:	$-12.24

FY	2021
Revenue:	$2.21M
Gross Profit:	$-4.66M (-211.14 %)
EPS:	$-0.320

FY	2020
Revenue:	$16.53M
Gross Profit:	$1.63M (9.88 %)
EPS:	$-0.640

Financial Reports:

No articles found.

Adamis Pharmaceuticals Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the treatment of asthma; and naloxone injection for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, and injectables; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California.